Manufacturer of Controlled Substances; Notice of Registration, 17470-17471 [05-6794]
Download as PDF
<![CDATA[
17470
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
of the proposed settlement agreement
may also be obtained by mail from the
Consent Decree Library, P.O. Box 7611,
U.S. Department of Justice, Washington,
DC 20044–7611, or by faxing or emailing a request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547.
In requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $12.50 (25 cents per
page reproduction cost) payable to the
U.S. Treasury.
W. Benjamin Fisherow,
Deputy Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 05–6844 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Notice of Lodging of Two Consent
Decrees Under the Comprehensive
Environmental Response,
Compensation and Liability Act
Under 28 CFR 50.7, notice is hereby
given that on March 23, 2005, two
proposed consent decrees in United
States v. Parker Hannifin Corporation
and Central Sprinkler Corporation, Civil
Action No. 05–1351, were lodged with
the United States District Court for the
Eastern District of Pennsylvania.
In this action the United States is
seeking injunctive relief and recovery of
response costs incurred by the United
States pursuant to the Compressive
Environmental Response, Compensation
and Liability Act (‘‘CERCLA’’), 42 U.S.C.
9601 et seq., in connection with the
Parker Hannifin/Precision Rebuilding
and the Central Sprinkler properties at
the North Penn Area Six Superfund Site
(‘‘Site’’), which consists of a
contaminated groundwater plume and a
number of separate parcels of property
located within and adjacent to the
Borough of Landsdale, Montgomery
County, Pennsylvania. The proposed
consent decrees will resolve the United
States’ claims against Parker Hannifin
Corporation and Central Sprinkler
Corporation (‘‘Settling Defendants’’) in
connection with Operable Unite 3 at the
Site. Under the terms of the proposed
consent decrees, Settling Defendants
will implement the EPA-selected
groundwater remedies at their
respective properties and reimburse the
United States for certain future response
costs. Settling Defendants will receive a
covenant not to sue by the United States
for performance of the work and for
recovery of past and future response
costs.
VerDate jul<14>2003
18:17 Apr 05, 2005
Jkt 205001
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the proposed consent
decrees. Comments should be addressed
to the Assistant Attorney General,
Environment and Natural Resources
Division, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. Parker Hannifin Corporation et
al, D.J. Ref. 90–11–2–06024/10.
The proposed consent decrees may be
examined at the Office of the United
States Attorney, 615 Chestnut Street,
Suite 1250, Philadelphia, PA 19106, and
at U.S. EPA Region III, 1650 Arch Street,
Philadelphia, PA 19103. During the
public comment period, the proposed
consent decrees may also be examined
on the following Department of Justice
Web site https://www.usdoj.gov/enrd/
open.html. A copy of one or both of the
proposed consent decrees may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy or copies from the Consent Decree
Library, please enclose a check in the
amount of $37.75 for a copy the
proposed consent decree with Parker
Hannifin Corporation, $38.25 for a copy
of the proposed consent decree with
Central Sprinkler Corporation, or $76.00
for copies of both (25 cents per page
reproduction cost). Checks should be
made payable to the U.S. Treasury.
Drug
Schedule
Manufacturer of Controlled
Substances; Notice of Registration
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
Gamma
hydroxybutyric
acid
(2010).
Methaqualone (2565) ...................
Lysergic acid dethylamide (7315)
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
2,5-Dimethoxyamophetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4-Methylenedioxy-methamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol Except LevoAlphacetylmethadol (9603).
Normethadone (9635) ..................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1-Piperidinocyclohexanecarbonitrile (8603).
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine Intermediate-A (9232)
Merperidine
Intermediate-B
(9233).
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
By Notice dated September 16, 2004,
and published in the Federal Register
on September 30, 2004, (69 FR 58541),
Aldrich Chemical Company Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
Ohio 45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Aldrich Chemical Company, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
Robert Brook,
Assistant Chief, Environmental Enforcement
Section, Environmental and Natural
Resources Division.
[FR Doc. 05–6846 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\06APN1.SGM
06APN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
17471
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Schedule
the public interest at this time. DEA has
investigated Aldrich Chemical
Company, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6794 Filed 4–5–05; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By notice dated December 21, 2004
and published in the Federal Register
on January 4, 2005 (70 FR 389),
Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Phenylacetone (8501), a basic class of
controlled substances listed in Schedule
II.
The company plans to import the
phenylacetone to manufacture
amphetamine for distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cambrex Charles City, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cambrex Charles City, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
18:17 Apr 05, 2005
Jkt 205001
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Correction
BILLING CODE 4410–09–P
VerDate jul<14>2003
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6797 Filed 4–5–05; 8:45 am]
By Notice dated December 21, 2004,
and published in the Federal Register
on January 4, 2005, (70 FR 390), the
listing of controlled substances N–
Ethylamphetamine (1475), 2,5–
Dimethoxyamphetamine (7396), 4–
Methoxyamphetamine (7411), and
Difenoxin (9168), were inadvertently
added for Chattem Chemicals, Inc., 3801
St. Elmo Avenue, Building 18,
Chattanooga, Tennessee 37409. The
Notice of Application should be
corrected by deleting N–
Ethylamphetamine (1475), 2,5–
Dimethoxyamphetamine (7396), 4–
Methoxyamphetamine (7411), and
Difenoxin (9168).
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6788 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
Drug
2,5–Dimethoxyamphetamine
(7396).
4–Methoxyamphetamine (7411) ...
Difenoxin (9168) ...........................
Methamphetamine (1105) ............
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
I
I
I
II
II
II
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. Sections 823(a) and
952(a) and determined that the
registration of Cambrex Charles City,
Inc. to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Cambrex Charles City,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
Sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substance listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6795 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Importer of Controlled Substances;
Notice of Registration
Drug Enforcement Administration
By Notice dated December 21, 2004
and published in the Federal Register
on January 4, 2005, (70 FR 390),
Chattem Chemicals Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in Schedule
I and II:
Drug
Schedule
N–Ethylamphetamine (1475) ........
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
I
Manufacturer of Controlled
Substances; Notice of Application;
Correction
By notice dated July 21, 2004, and
published in the Federal Register on
August 10, 2004 (69 FR 48522), Dade
Behring Inc., Route 896 Corporate
Boulevard, Building 100, Attention: RA/
QA, Post Office Box 6101, Newark,
Delaware 19717 made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer, and to modify its
address. The address modification was
inadvertently omitted. The state of
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Pages 17470-17471]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6794]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated September 16, 2004, and published in the Federal
Register on September 30, 2004, (69 FR 58541), Aldrich Chemical Company
Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
Gamma hydroxybutyric acid (2010)........... I
Methaqualone (2565)........................ I
Lysergic acid dethylamide (7315)........... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
2,5-Dimethoxyamophetamine (7396)........... I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxy-methamphetamine (7405).. I
4-Methoxyamphetamine (7411)................ I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Acetylmethadol (9601)...................... I
Alphacetylmethadol Except Levo- I
Alphacetylmethadol (9603).
Normethadone (9635)........................ I
3-Methylfentanyl (9813).................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexane-carbonitrile (8603) II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Meperidine Intermediate-A (9232)........... II
Merperidine Intermediate-B (9233).......... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Dextropropoxyphene, bulk, (non-dosage II
forms) (9273).
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to produce isotope labeled standards for drug
analysis.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Aldrich Chemical Company, Inc. to manufacture the listed basic classes
of controlled substances is consistent with
[[Page 17471]]
the public interest at this time. DEA has investigated Aldrich Chemical
Company, Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6794 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P
